APV-202701-A

N/A

Report date: 2023/02/19 22:08:09
NME

Base Information

Drug NameAPV-202701-A
Drug Alias NameAPV-202701-A
ClassificationSmall molecules
Mechanisms of ActionDopamine D3 receptor antagonists
TargetsDopamine D3 receptor
Therapy Area/IndicationsSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndivior PLC
China Registration ClassN/A

Develop Information

Active CompaniesIndivior PLC
Inactive CompaniesN/A
Active IndicationsSubstance-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A